CVE-2020-14490 | BDVDB-2026-139596 Detail

open sourceOpenClinic GA

Description#

OpenClinic GA 5.09.02 and 5.89.05b includes arbitrary local files specified within its parameter and executes some files, which may allow disclosure of sensitive files or the execution of malicious uploaded files.

Impact#

Per CVSS v3.1: confidentiality impact high, integrity impact high, availability impact high. Attack vector: network.

Weaknesses#

CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

References#

https://us-cert.cisa.gov/ics/advisories/ICSMA-20-184-01

Exploit#

No public exploit known

History#

Version 12020-07-29Record published in the CVE List.
Version 22024-09-16Most recent update recorded in the CVE List.

Published

Published: 2020-07-29
Last modified: 2024-09-16

Vendor information

Vendor: open source
Product: OpenClinic GA

All open source vulnerabilities

Score

8.8 High

EPSS

2.4%, Low

Estimated chance of exploitation in the next 30 days. EPSS percentile: 84.5.

KEV

Not listed in the CISA Known Exploited Vulnerabilities catalog.

Impact

Path Traversal

Action

No specific action is recorded in the source data. Check the references for vendor guidance.

Affected Systems

Vulnerable
5.09.02
Fixed
Not stated
Vulnerable
5.89.05b
Fixed
Not stated

Scoring System

CVSS v4.0

Not available

CVSS v3.1

8.8 High

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Metric breakdown
Attack Vector	Network
Attack Complexity	Low
Privileges Required	Low
User Interaction	None
Scope	Unchanged
Confidentiality	High
Integrity	High
Availability	High

CVSS v3.0

Not available

CVSS v2

Not available

Source: CVE List v5 (record); CISA KEV (kev, action); FIRST EPSS (epss).